Please sign in to follow a disease.

Alcohol-associated liver disease

Clinical trials for Alcohol-associated liver disease explained in plain language.

Never miss a new study

Get alerted when new Alcohol-associated liver disease trials appear

Sign up with your email to follow new studies for Alcohol-associated liver disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 4 Not yet recruiting 3 Not yet finished but already full! 1 Completed 2

New drug aims to reverse liver damage from heavy drinking

Disease control Ongoing

This study tests a weekly injection called pemvidutide in 100 adults with alcohol-related liver disease. Participants are overweight or obese and have a history of heavy drinking. The goal is to see if the drug can reduce liver stiffness and scarring over 24 to 48 weeks compared …

Matched conditions: ALCOHOL-ASSOCIATED LIVER DISEASE

Phase 2 • Sponsor: Altimmune, Inc. • Aim: Disease control

Last updated Aug 19, 2026 00:00 UTC

Alcohol-associated liver disease

Get alerted when new Alcohol-associated liver disease trials appear

New drug aims to reverse liver damage from heavy drinking